Citation: N. Akar et al., Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation, J CHILD NEU, 16(4), 2001, pp. 294-295
Authors:
Cakar, N
Yalcinkaya, F
Ozkaya, N
Tekin, M
Akar, N
Kocak, H
Misirlioglu, M
Akar, E
Tumer, N
Citation: N. Cakar et al., Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome, CLIN EXP RH, 19(5), 2001, pp. S63-S67
Authors:
Gulec, S
Aras, O
Akar, E
Tutar, E
Omurlu, K
Avci, F
Dincer, I
Akar, N
Oral, D
Citation: S. Gulec et al., Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction, CLIN CARD, 24(4), 2001, pp. 281-284
Authors:
Akar, N
Duman, T
Akar, E
Deda, G
Sipahi, L
Citation: N. Akar et al., The alpha 2 gene alleles of the platelet collagen receptor integrin alpha 2 beta 1 in Turkish children with cerebral infarct, THROMB RES, 102(2), 2001, pp. 121-123
Authors:
Yalcinkaya, F
Tekin, M
Cakar, N
Akar, E
Akar, N
Tumer, N
Citation: F. Yalcinkaya et al., Familial Mediterranean fever and systemic amyloidosis in untreated Turkishpatients, QJM-MON J A, 93(10), 2000, pp. 681-684
Citation: N. Akar et al., Coexistence of factor V 1691 G-A and factor V 4070 A-G mutation in Turkishthromboembolic patients, AM J HEMAT, 65(1), 2000, pp. 88-88
Authors:
Akar, N
Yilmaz, E
Akar, E
Avcu, F
Yalcin, A
Cin, S
Citation: N. Akar et al., Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A, THROMB RES, 97(4), 2000, pp. 227-230
Authors:
Akar, N
Akar, E
Akcay, R
Avcu, F
Yalcin, A
Cin, S
Citation: N. Akar et al., Effect of metylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients, THROMB RES, 97(3), 2000, pp. 163-167
Authors:
Avcu, F
Akar, N
Akar, E
Beyan, C
Yalcin, A
Citation: F. Avcu et al., Prothrombin gene 20210 G -> A and Factor V Arg 506 to Gln mutation in a patient with Buerger's disease - A case report, ANGIOLOGY, 51(5), 2000, pp. 421-423
Authors:
Akar, N
Akar, E
Deda, G
Sipahi, T
Ezer, U
Citation: N. Akar et al., Coexistence of two prothrombotic mutations, factor V 1691 G-A and prothrombin gene 20210 G-A, and the risk of cerebral infarct in pediatric patients, PED HEM ONC, 16(6), 1999, pp. 565-566
Authors:
Akar, N
Akar, E
Deda, G
Sipahi, T
Orsal, A
Citation: N. Akar et al., Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct, J CHILD NEU, 14(11), 1999, pp. 749-751
Citation: N. Akar et al., Feasibility of restriction enzyme protocols for the molecular diagnosis ofabnormal hemoglobins in Turkish population, AM J HEMAT, 62(3), 1999, pp. 198-198
Authors:
Akar, N
Akar, E
Cin, S
Deda, G
Avcu, F
Yalcin, A
Citation: N. Akar et al., Endothelial nitric oxide synthase intron 4, 27 bp repeat polymorphism in Turkish patients with deep vein thrombosis and cerebrovascular accidents, THROMB RES, 94(1), 1999, pp. 63-64
Citation: N. Akar et E. Akar, Methylenetetrahydrofolate-dehydrogenase 1958 G-A (R653 Q) polymorphism in Turkish patients with venous thromboembolism, ACT HAEMAT, 102(4), 1999, pp. 199-200